Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease
Stefano Barco·Nils Kucher·Rolf P. Engelberger·Ulrike Held·Riccardo M. Fumagalli·A Grigorean·D. Hayoz·Mario Münger·Tim Sebastian·Roman Stadler·Davide Voci·Simon Wolf·Frédéric Baumann·Conrad von Stempel·Tobias Tritschler·Daniel Périard
Among patients with infrainguinal artery disease undergoing endovascular treatment, angioplasty with sirolimus-coated balloons led to a lower incidence of major adverse limb events at 1 year than angioplasty with uncoated balloons. (Funded by Concept Medical and others; SirPAD ClinicalTrials.gov number, NCT04238546.).